The controversial diabetes pill failed to significantly slow plaque buildup in the arteries compared with an older drug, Pfizer's Gluctrol, according to a study presented at the American Heart Association meeting. The new study tested Avandia against Glucotrol in 672 people in 19 countries who Type 2 diabetes with a high risk for heart problems and many were very overweight. After 18 months, those who took Avandia had an 0.21 percent reduction in plaque in a heart artery, while the Gluctrol pa
No comments:
Post a Comment